Human CD14 promoter polymorphisms were involved in sensitization to allergens [22], atopic dermatitis [23], cardio-vascular diseases [24–27], tuberculosis and HIV infection [28–30], acute diarrhoea [31] and IBD [32–34]. This evidence concerns the gene CD14 and inflammatory bowel disease.